ClassID:

21579

A61K51/088 - page 3 - CPC Classification

Classification description:

Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds; Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins

Recent Application in this class:
#601
20150190527
2015-07-09

Bladder cancer specific ligand peptides

#602
20150182643
2015-07-02

Substrate based PET imaging agents

#603
20150174274
2015-06-25

Modulation of immunity and CEACAM1 activity

#604
20150165076
2015-06-18

Anti-mucin antibodies for early detection and treatment of pancreatic cancer

#605
20150157747
2015-06-11

Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same

#606
20150150912
2015-06-04

CEACAM1 mediated protective immunity

#607
20150132222
2015-05-14

Methods and compositions for positron emission tomography myocardial perfusion imaging

#608
20150132220
2015-05-14

Compositions and Imaging Methods Comprising Detectably Labeled Phosphatidylethanolamine-Binding Peptides

#609
20150132219
2015-05-14

177-Lu labeled peptide for site-specific uPAR-targeting

#610
20150111279
2015-04-23

Class I anti-CEA antibodies and uses thereof

#611
20150104388
2015-04-16

ANALOGS OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND METHODS FOR THEIR USE

#612
20150104381
2015-04-16

Enhanced in vivo targeting of radiolabelled peptides with the means of enzyme inhibitors

#613
20150086482
2015-03-26

Dye Conjugated Peptides for Fluorescent Imaging

#614
20150086481
2015-03-26

DIAGNOSIS AND TREATMENT OF PARKINSON'S DISEASE

#615
20150078999
2015-03-19

Cyclic peptides as protein targeting agents

#616
20150071855
2015-03-12

EGFL7 targeting and/or binding polypeptides and methods for inhibiting angiogenesis

#617
20150056137
2015-02-26

Caspase-triggered nano-aggregation probes and methods of use

#618
20150051392
2015-02-19

Functionalisation of cage amine ligands for metallo-radiopharmaceuticals

#619
20150051153
2015-02-19

Environmentally sensitive compositions and methods of use in the treatment and diagnosis of tumors

#620
20150050715
2015-02-19

Stably tethered structures of defined compositions with multiple functions or binding specificities

#621
20150050211
2015-02-19

Methods for preparing high throughput peptidomimetics, orally bioavailable drugs and compositions containing same

#622
20150030537
2015-01-29

Chlorotoxin polypeptides and conjugates and uses thereof

#623
20150023872
2015-01-22

Homing agents

#624
20150010557
2015-01-08

Method for delivering alpha-melanocyte stimulating hormone mimetibody composition comprising propylene glycol for intranasal administration to the central nervous system

#625
20150005474
2015-01-01

Recognition molecules for the treatment and detection of tumors

#626
20150004099
2015-01-01

Targeting of chondroitin sulfate glycans

#627
20140377177
2014-12-25

Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules

#628
20140377173
2014-12-25

Anti-mucin antibodies for early detection and treatment of pancreatic cancer

#629
20140377171
2014-12-25

Imaging and Treatment of Neuroendocrine Tumors with Glucose - Dependent Insulinotropic Polypeptide or Analogues or Antagonists Thereof

#630
20140377170
2014-12-25

Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells

#631
20140363377
2014-12-11

PROCASPASE 8-MEDIATED DISEASE TARGETING

#632
20140363376
2014-12-11

Molecular design toward dual-modality probes for radioisotope-based imaging (PET or SPECT) and MRI

#633
20140357578
2014-12-04

Therapeutic approach for polyglutamine degeneration

#634
20140356284
2014-12-04

Hydrophobic modified peptides for liver specific diagnosis

#635
20140341807
2014-11-20

Pet tracer for imaging of neuroendocrine tumors

#636
20140341804
2014-11-20

Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof

#637
20140335018
2014-11-13

Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging

#638
20140323718
2014-10-30

Cage amine ligands for metallo-radiopharmaceuticals

#639
20140314670
2014-10-23

CLICKED SOMATOSTATIN CONJUGATED ANALOGS FOR BIOLOGICAL APPLICATIONS

#640
20140314669
2014-10-23

Compounds for binding to the platelet specific glycoprotein IIB/IIIA and their use for imaging of thrombi

#641
20140314668
2014-10-23

TECHNETIUM-99M LABELED COMPLEX OF GOLD NANOPARTICLE-GOLD BINDING PEPTIDES, AND METHOD OF MAKING AND USING THE SAME

#642
20140308278
2014-10-16

Class I anti-CEA antibodies and uses thereof

#643
20140294730
2014-10-02

Compositions and methods for diagnosing and monitoring ovarian cancer progression and treatment

#644
20140286865
2014-09-25

SYNTHETIC DIBLOCK COPOLYPEPTIDE HYDROGELS FOR USE IN THE CENTRAL NERVOUS SYSTEM

#645
20140286864
2014-09-25

KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy

#646
20140286863
2014-09-25

Complexation of fatty acid-conjugated molecules with albumin

#647
20140271469
2014-09-18

Cystine knot peptides that bind alpha-V-beta-6 integrin

#648
20140271467
2014-09-18

Probes and methods of imaging non-Hodgkins lymphoma

#649
20140227181
2014-08-14

Method of labelling a biologically active molecule with 5-fluoro-5-deoxypentose or a 3-fluoro-3-deoxypentose

#650
20140227179
2014-08-14

Anti-mucin antibodies for early detection and treatment of pancreatic cancer

#651
20140221271
2014-08-07

SHK-based pharmaceutical compositions and methods of manufacturing and using the same

#652
20140213757
2014-07-31

CASSETTE FOR RADIOPHARMACEUTICAL SYNTHESIS

#653
20140200329
2014-07-17

BISAMINOETHANETHIOL-TARGETING LIGAND CONJUGATES AND COMPOSITIONS

#654
20140194369
2014-07-10

Cyclic lactadherin peptide mimetics and their uses

#655
20140193359
2014-07-10

Stable compositions of high-concentration allotype-selected antibodies for small-volume administration

#656
20140178301
2014-06-26

Polypeptides

#657
20140178299
2014-06-26

Methods and compositions for detection of cancer

#658
20140178294
2014-06-26

Ultrafiltration concentration of allotype selected antibodies for small-volume administration

#659
20140171637
2014-06-19

Process for the preparation of complexes of Ga

#660
20140170064
2014-06-19

Methods and compositions for radiohalogen protein labeling

#661
20140161732
2014-06-12

KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy

#662
20140161723
2014-06-12

In vivo methods of monitoring biodistribution

#663
20140147385
2014-05-29

Compounds for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same

#664
20140140925
2014-05-22

FOLATE-TARGETED DIAGNOSTICS AND TREATMENT

#665
20140127139
2014-05-08

Compounds for diagnosing diseases associated with the expression of MUC5AC

#666
20140127128
2014-05-08

Molecular Probe for Imaging of Pancreatic Islets and Use of the Same

#667
20140113872
2014-04-24

Agonists and antagonists of the urotensinergic system

#668
20140112866
2014-04-24

Positron emission tomography imaging method

#669
20140107041
2014-04-17

KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy

#670
20140105819
2014-04-17

In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents

#671
20140065069
2014-03-06

Materials and Methods Relating to Cardiovascular Imaging

#672
20140065068
2014-03-06

Vitamin-targeted imaging agents

#673
20140065065
2014-03-06

Tc imaging agents and methods of use

#674
20140056810
2014-02-27

Conjugates and their uses in molecular imaging

#675
20140038261
2014-02-06

Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity

#676
20140023585
2014-01-23

177 LUTETIUM-LABELED BOMBESIN ANALOGS FOR RADIOTHERAPY

#677
20140004041
2014-01-02

Technetium labelled peptides

#678
20140004040
2014-01-02

Methods and compositions for targeting sites of neovascular growth

#679
20140004039
2014-01-02

RGD mimetic γ-AApeptides and methods of use

#680
20130343990
2013-12-26

Radiolabelled octreotate analogues as PET tracers

#681
20130323171
2013-12-05

RADIOLABELED BBN ANALOGS FOR PET IMAGING OF GASTRIN-RELEASING PEPTIDE RECEPTORS

#682
20130323170
2013-12-05

Prosthetic groups attached to stannyl polymer in the synthesis of radiopharmaceuticals

#683
20130323168
2013-12-05

Agents and methods for visualizing analytes

#684
20130316962
2013-11-28

Muteins of hNGAL and related proteins with affinity for a given target

#685
20130315821
2013-11-28

Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules

#686
20130295010
2013-11-07

HER2 BINDING PEPTIDES LABELLED WITH A 18F - CONTAINING ORGANOSILICON COMPOUND

#687
20130287685
2013-10-31

HER2 binding peptides labeled with aluminium-[18] fluoride complexed by NOTA

#688
20130287681
2013-10-31

Somatostatin receptor-based cancer therapy

#689
20130259804
2013-10-03

Radiotracer compositions

#690
20130259803
2013-10-03

Radioconjugation method

#691
20130251632
2013-09-26

APOPTOSIS PET IMAGING AGENTS

#692
20130243691
2013-09-19

Agents for the molecular imaging of serine-protease in human pathologies

#693
20130237687
2013-09-12

Vitamin-targeted imaging agents

#694
20130224256
2013-08-29

Hydrogel nanocomposite wound dressing and a method of synthesizing the same

#695
20130195756
2013-08-01

99mTc IMAGING AGENTS AND METHODS OF USE

#696
20130189186
2013-07-25

APOPTOSIS IMAGING AGENTS BASED ON LANTIBIOTIC PEPTIDES

#697
20130165631
2013-06-27

BISAMINOETHANETHIOL-TARGETING LIGAND CONJUGATES AND COMPOSITIONS

#698
20130157338
2013-06-20

RHAMM binding peptides

#699
20130149241
2013-06-13

Peptide radiotracer compositions

#700
20130149240
2013-06-13

99mTc-LABELED TRIPHENYLPHOSPHONIUM DERIVATIVE CONTRASTING AGENTS AND MOLECULAR PROBES FOR EARLY DETECTION AND IMAGING OF BREAST TUMORS

#701
20130144035
2013-06-06

COMPOSITIONS AND METHODS FOR LEUKOCYTE-TARGETING MULTI-VALENT IMAGING PROBES

#702
20130136691
2013-05-30

GASTRIN RELEASING PEPTIDE COMPOUNDS

#703
20130129623
2013-05-23

Radiopharmaceutical compositions

#704
20130129622
2013-05-23

Cyclopentapeptide derivatives and uses thereof

#705
20130129621
2013-05-23

Integrin receptor antagonists and their methods of use

#706
20130095033
2013-04-18

Multivalent antibody complexes targeting IGF-1R show potent toxicity against solid tumors

#707
20130078188
2013-03-28

Activatable cell penetrating peptides with quenched fluorophores

#708
20130065816
2013-03-14

Analogs of pituitary adenylate cyclase-activating polypeptide (PACAP) and methods for their use

#709
20130064766
2013-03-14

Tricarbonyl technetium-99m, rhenium-185/187, or rhenium-188 labeled cyclic RGD derivatives and uses thereof

#710
20130059793
2013-03-07

EGF RECEPTOR MIMICKING PEPTIDES

#711
20130058865
2013-03-07

99mTc-labeled 19 amino acid containing peptide for use as phosphatidylethanolamine binding molecular probe and radiopharmaceutical

#712
20130052132
2013-02-28

Method for Producing Radioactively Labeled Polypeptide

#713
20130045533
2013-02-21

Modular transport platform for targeted delivery of therapeutic agents

#714
20130039861
2013-02-14

Dye Conjugated Peptides for Fluorescent Imaging

#715
20130034492
2013-02-07

Class I anti-CEA antibodies and uses thereof

#716
20130028836
2013-01-31

Chlorotoxin polypeptides and conjugates and uses thereof

#717
20130011900
2013-01-10

Nucleophilic catalysts for oxime linkage

#718
20130005653
2013-01-03

Polypeptides

#719
20130004423
2013-01-03

Polyazamacrocyclic compound, and a production method and a biomedical use therefor

#720
20120321553
2012-12-20

Ultrafiltration concentration of allotype selected antibodies for small-volume administration

#721
20120315220
2012-12-13

Compounds for Targeting Endothelial Cells, Compositions Containing the Same and Methods for Their Use

#722
20120308583
2012-12-06

USE OF GCC LIGANDS

#723
20120294801
2012-11-22

Conjugates of RGD peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses

#724
20120288445
2012-11-15

RADIOLABELLING

#725
20120282178
2012-11-08

Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules

#726
20120282171
2012-11-08

Radiolabelling methods

#727
20120276608
2012-11-01

Multivalent Immunoglobulin-Based Bioactive Assemblies

#728
20120270812
2012-10-25

COMPOSITIONS, METHODS, AND KITS FOR DETERMINING AN ALKYL TRANSFERASE

#729
20120259092
2012-10-11

NPY ANTAGONISTS

#730
20120253010
2012-10-04

Compound accumulating in inflammatory site, diagnostic agent containing the compound in labeled state and its precursor compound for labeling

#731
20120251446
2012-10-04

Peptide Conjugates Comprising Polyhistidine Sequence and Free Cysteine and Their Uses in Imaging

#732
20120244070
2012-09-27

Fibronectin targeting contrast agent

#733
20120230994
2012-09-13

Bladder cancer specific ligand peptides

#734
20120225016
2012-09-06

Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same

#735
20120219499
2012-08-30

Compositions and methods for detecting plectin-1 as a biomarker for cancer

#736
20120219495
2012-08-30

Tetraaza macrocyclic compound, preparation method thereof and use thereof

#737
20120214969
2012-08-23

Methods and compositions for F-18 labeling of proteins, peptides and molecules

#738
20120207676
2012-08-16

Neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors

#739
20120195828
2012-08-02

Kidney-imaging agent comprising recombinant gelatin

#740
20120178906
2012-07-12

CHELATION OF METALS TO THIOL GROUPS USING IN SITU REDUCTION OF DISULFIDE-CONTAINING COMPOUNDS BY PHOSPHINES

#741
20120177571
2012-07-12

PANCREATIC ENDOCRINE CELL INDICATING AGENT AND UTILIZATION OF SAME

#742
20120172283
2012-07-05

Methods and compositions for targeted drug delivery

#743
20120171117
2012-07-05

Radiofluorinated compounds and their preparation

#744
20120165650
2012-06-28

HER2 BINDERS

#745
20120164071
2012-06-28

Compositions and methods comprising phosphatidylethanolamine-binding peptide derivatives

#746
20120156134
2012-06-21

COMPOSITIONS AND METHODS FOR DETECTING OR ELIMINATING SENESCENT CELLS TO DIAGNOSE OR TREAT DISEASE

#747
20120156132
2012-06-21

Targeting agent to newly formed blood vessels

#748
20120156131
2012-06-21

DIAGNOSIS AND TREATMENT OF TUMORS

#749
20120141375
2012-06-07

Anti-mucin antibodies for early detection and treatment of pancreatic cancer

#750
20120134923
2012-05-31

Radioiodination method

#751
20120134920
2012-05-31

Methods and compositions for improved F labeling of proteins, peptides and other molecules

#752
20120128587
2012-05-24

FOLATE-TARGETED DIAGNOSTICS AND TREATMENT

#753
20120122788
2012-05-17

ε-Polylysine conjugates and the use thereof

#754
20120121507
2012-05-17

Peptide ligands for clusterin and uses thereof

#755
20120107243
2012-05-03

PEPTIDE-MEDIATED NON-COVALENT DELIVERY OF ACTIVE AGENTS ACROSS THE BLOOD-BRAIN BARRIER

#756
20120107237
2012-05-03

Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptide for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same

#757
20120100072
2012-04-26

PET IMAGING OF FIBROGENESIS

#758
20120100071
2012-04-26

SYNTHESIS AND USE OF RADIOLABELLED INSULIN ANALOGUES

#759
20120100070
2012-04-26

Cyclic peptide analogues for non-invasive imaging of pancreatic beta-cells

#760
20120093722
2012-04-19

Synthetic diblock copolypeptide hydrogels for use in the central nervous system

#761
20120089017
2012-04-12

LIGANDS TO RADIATION-INDUCED MOLECULES

#762
20120087863
2012-04-12

Peptide derivative and use of the same

#763
20120082619
2012-04-05

Labelled adrenomedullin derivatives and their use for imaging and therapy

#764
20120076727
2012-03-29

In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents

#765
20120065367
2012-03-15

Radioactively Labeled Substance

#766
20120065365
2012-03-15

Stable Radiopharmaceutical Compositions and Methods for Their Preparation

#767
20120053318
2012-03-01

METHOD OF RADIOLABELING

#768
20120052009
2012-03-01

Imaging probes, methods of making imaging probes, and methods of imaging

#769
20120045393
2012-02-23

LHRH-II PEPTIDE ANALOGS

#770
20120034163
2012-02-09

NON-INVASIVE TOOLS FOR DETECTING VULNERABLE ATHEROSCLEROTIC PLAQUES

#771
20120020882
2012-01-26

Peptide-based compounds

#772
20120020881
2012-01-26

Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes

#773
20120017892
2012-01-26

Use of salt of an acetylsalicylic acid for the treatment of viral infections

#774
20120014873
2012-01-19

Peptides whose uptake by cells is controllable

#775
20120009122
2012-01-12

Gastrin releasing peptide compounds

#776
20110313130
2011-12-22

Bifunctional chelating agents

#777
20110305632
2011-12-15

PROCESS FOR THE PREPARATION OF ASYMMETRICAL BIS(THIOSEMICARBAZONES)

#778
20110301340
2011-12-08

Toxins and radionuclides coupled to IGF-1 receptor ligands for treatment of cancer

#779
20110300071
2011-12-08

TARGETING NPR-C IN ANGIOGENESIS AND ATHEROSCLEROSIS WITH A C-TYPE ATRIAL NATRIURETIC FACTOR (CANF)-COMB NANOCOMPLEX

#780
20110300070
2011-12-08

BIOMOLECULE COMPLEXES AS CONTRAST AGENTS IN POSITRON EMISSION TOMOGRAPHY (PET) BASED METHODS FOR THE ASSESSMENT OF ORGAN FUNCTION

#781
20110293517
2011-12-01

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

#782
20110288152
2011-11-24

PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING

#783
20110280802
2011-11-17

Linkers For Radiopharmaceutical Compounds

#784
20110280801
2011-11-17

Methods and compositions for F-18 labeling of proteins, peptides and other molecules

#785
20110274704
2011-11-10

Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity

#786
20110269943
2011-11-03

RADIOLABELED ANNEXINS

#787
20110262366
2011-10-27

COMPOUNDS FOR TARGETING ENDOTHELIAL CELLS, COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THEIR USE

#788
20110262353
2011-10-27

Muteins of hNGAL and related proteins with affinity for a given target

#789
20110251486
2011-10-13

Radiolabeled annexins

#790
20110251136
2011-10-13

Glue composition for lung volume reduction

#791
20110250133
2011-10-13

GASTRIN RELEASING PEPTIDE COMPOUNDS

#792
20110236316
2011-09-29

PEPTIDE TARGETING IMAGING AGENTS AND METHODS OF USE THEREOF

#793
20110236311
2011-09-29

Radiolabelling methods

#794
20110223102
2011-09-15

MULTIMODALITY AGENTS FOR TUMOR IMAGING AND THERAPY

#795
20110213293
2011-09-01

Ligands to radiation-induced molecules

#796
20110206615
2011-08-25

Probe reagent for measuring oxidative stress

#797
20110206606
2011-08-25

STABLE RADIOPHARMACEUTICAL COMPOSITIONS AND METHODS FOR PREPARATION

#798
20110206605
2011-08-25

Molecular probe for imaging of pancreatic islets and use of the same

#799
20110182989
2011-07-28

Peptide compositions and therapeutic uses thereof

#800
20110171129
2011-07-14

Molecular probe precursor for imaging of pancreatic islet, and use thereof

#801
20110171122
2011-07-14

Methods and compositions for the detection of cancer

#802
20110165611
2011-07-07

DUAL MODALITY DETECTION OF APOPTOSIS

#803
20110165072
2011-07-07

Detection of early-stage pancreatic adenocarcinoma

#804
20110165067
2011-07-07

CARBOHYDRATE FUNCTIONALIZED CATANIONIC SURFACTANT VESICLES FOR DRUG DELIVERY

#805
20110143417
2011-06-16

Stably tethered structures of defined compositions with multiple functions or binding specificities

#806
20110136741
2011-06-09

DICARBA-ANALOGUES OF OCTREOTIDE

#807
20110129462
2011-06-02

Intranasal administration of active agents to the central nervous system

#808
20110123988
2011-05-26

ANTISENSE COMPOUNDS AND METHODS FOR DIAGNOSTIC IMAGING

#809
20110123445
2011-05-26

TREATMENT MONITORING

#810
20110117016
2011-05-19

Diagnostic compounds

#811
20110117012
2011-05-19

RADIOLABELED GALLIUM COMPLEXES, METHODS FOR SYNTHESIS AND USE FOR PET IMAGING OF EGFR EXPRESSION IN MALIGNANT TUMORS

#812
20110110855
2011-05-12

Ghrelin analogues

#813
20110110854
2011-05-12

Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules

#814
20110110851
2011-05-12

Multivalent immunoglobulin-based bioactive assemblies

#815
20110097275
2011-04-28

KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy

#816
20110097267
2011-04-28

COMPOSITIONS FOR IMAGING PAIN AND STRESS IN VIVO

#817
20110097266
2011-04-28

Bombesin analog peptide antagonist conjugates

#818
20110092806
2011-04-21

Compounds comprising a biological target recognizing part, coupled to a signal part capable of complexing gallium

#819
20110091460
2011-04-21

Receptor-targeting reagents containing epidermal factor receptor-binding agents and IL-13 receptor-binding agents or IL-4 receptor-binding agents

#820
20110085986
2011-04-14

Diagnosis and treatment of epithelial cancers using labeled/conjugated progastrin peptides

#821
20110082280
2011-04-07

Methods Of Coupling Multidentate AZA Ligands To Targeting Molecules

#822
20110076233
2011-03-31

Delivery system for cytotoxic drugs by bispecific antibody pretargeting

#823
20110064658
2011-03-17

RGD-(bacterio)chlorophyll conjugates for photodynamic therapy and Imaging of Necrotic tumors

#824
20110064653
2011-03-17

Class I anti-CEA antibodies and uses thereof

#825
20110059483
2011-03-10

Molecular probe for imaging of pancreatic islets and use of the same

#826
20110052491
2011-03-03

Gastrin releasing peptide compounds

#827
20110038798
2011-02-17

Agents for detecting and imaging cell death

#828
20110033380
2011-02-10

Compounds and methods for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same

#829
20110027175
2011-02-03

Cancer imaging and treatment

#830
20110020273
2011-01-27

Bispecific Immunocytokine Dock-and-Lock (DNL) Complexes and Therapeutic Use Thereof

#831
20110020223
2011-01-27

Polypeptides having affinity for HER2

#832
20100324008
2010-12-23

PSMA binding ligand-linker conjugates and methods for using

#833
20100322857
2010-12-23

RADIOLABELLED PEPTIDE BASED COMPOUNDS AND USES THEREOF

#834
20100322854
2010-12-23

Positron emission tomography imaging method

#835
20100316572
2010-12-16

Use of FSH receptor ligands for diagnosis and therapy of cancer

#836
20100316566
2010-12-16

RADIOLABELED HEDGEHOG DERIVATIVES FOR IMAGING AND THERAPY

#837
20100272644
2010-10-28

Complexation of fatty acid-conjugated molecules with albumin

#838
20100272643
2010-10-28

Procaspase 8-mediated disease targeting

#839
20100267928
2010-10-21

ACTIVATABLE DIAGNOSTIC AND THERAPEUTIC COMPOUND

#840
20100261207
2010-10-14

Methods of diagnosing and prognosing hodgkin's lymphoma

#841
20100256331
2010-10-07

68Ga-Labelling of a Free and Macromolecule Conjugated Macrocyclic Chelator at Ambient Temperature

#842
20100240072
2010-09-23

Cancer imaging and treatment

#843
20100233082
2010-09-16

68GA-Labeled Peptide-Based Radiopharmaceuticals

#844
20100227794
2010-09-09

SMART CONTRAST AGENT AND METHOD FOR DETECTING TRANSITION METAL IONS AND TREATING RELATED DISORDERS

#845
20100221183
2010-09-02

PEPTIDES FOR TREATING AND DIAGNOSING CANCERS AND METHODS FOR USING THE SAME

#846
20100204457
2010-08-12

Preparation of annexin derivatives

#847
20100196271
2010-08-05

Cage-like bifunctional chelators, copper-64 radiopharmaceuticals and PET imaging using the same

#848
20100196270
2010-08-05

Radiofluorination methods

#849
20100191096
2010-07-29

PARAMAGNETIC BIOMOLECULE COMPLEXES AND USES THEREOF IN THE ASSESSMENT OF ORGAN FUNCTION

#850
20100189643
2010-07-29

DRUG DELIVERY WITH STIMULUS RESPONSIVE BIOPOLYMERS

#851
20100183510
2010-07-22

EphB receptor-binding peptides

#852
20100129290
2010-05-27

SMART CONTRAST AGENT AND DETECTION METHOD FOR DETECTING TRANSITION METAL IONS

#853
20100121031
2010-05-13

MEMBRANE-PERMEANT PEPTIDE COMPLEXES FOR TREATMENT OF SEPSIS

#854
20100074910
2010-03-25

Achievement of a high therapeutic index through molecular imaging guided targeted drug treatment

#855
20100074844
2010-03-25

Cyclopeptides containing RGD mimetics as imaging markers for integrins

#856
20100074843
2010-03-25

Substrate based PET imaging agents

#857
20100069628
2010-03-18

Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy

#858
20100069609
2010-03-18

CHEMICAL METHODS AND APPARATUS

#859
20100068151
2010-03-18

MULTIMODALITY MOLECULAR IMAGING WITH THERAPEUTIC CONJUGATES

#860
20100068139
2010-03-18

Methods of radiofluorination of biologically active vectors

#861
20100061932
2010-03-11

PEPTIDES USEFUL AS CELL-PENETRATING PEPTIDES

#862
20100061930
2010-03-11

ErbB-2 receptor targeting peptide

#863
20100055035
2010-03-04

Bisaminoethanethiol-targeting ligand conjugates and compositions

#864
20100041073
2010-02-18

Two helix binders

#865
20100040550
2010-02-18

Radiolabelling methods

#866
20100040543
2010-02-18

Tc-labeled 19 amino acid containing peptide for use as phosphatidylethanolamine binding molecular probe and radiopharmaceutical

#867
20100040542
2010-02-18

Chelator conjugates

#868
20100034740
2010-02-11

Radiofluorination methods

#869
20100034739
2010-02-11

Fungus-Specific Imaging Agents

#870
20100022746
2010-01-28

Synthesis of a radiofluorinated peptide using photolabile protecting groups

#871
20100021381
2010-01-28

Natriuretic peptide-mediated imaging of atherosclerotic plaque

#872
20100016551
2010-01-21

Synthesis of radiofluorinated peptide using microwave activation technology

#873
20100015058
2010-01-21

RADIOLABELED BBN-RGD HETERODIMERS FOR CANCER TARGETING

#874
20100015051
2010-01-21

Transferrin-conjugated nanoparticles for increasing efficacy of a therapeutic agent

#875
20100015044
2010-01-21

Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases

#876
20100008858
2010-01-14

Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules

#877
20100008857
2010-01-14

Hexatriene-β-carbonyl compound

#878
20100008852
2010-01-14

Bi-specific monoclonal antibody (specific for both CD3 and CD11B) therapeutic drug

#879
20100003195
2010-01-07

KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy

#880
20090324499
2009-12-31

Vitamin-targeted imaging agents

#881
20090324497
2009-12-31

Tc and Re labeled radioactive glycosylated octreotide derivatives

#882
20090317326
2009-12-24

RADIOFLUORINATION METHODS

#883
20090311177
2009-12-17

Radiolabelling methods

#884
20090304586
2009-12-10

Chelating agent conjugated α-MSH peptide derivatives, preparation method thereof and composition for diagnosis and treatment of melanoma comprising the same as an active ingredient

#885
20090304580
2009-12-10

Anti-pancreatic cancer antibodies

#886
20090299033
2009-12-03

Methods and compositions for F-18 labeling of proteins, peptides and other molecules

#887
20090280057
2009-11-12

Combination of intercalating organometallic complexes and tumor seeking biomolecules for DNA cleavage and radiotherapy

#888
20090274623
2009-11-05

IN VIVO IMAGING AGENTS FOR MET RECEPTOR TYROSINE KINASE

#889
20090269277
2009-10-29

Multivalent immunoglobulin-based bioactive assemblies

#890
20090263320
2009-10-22

Peptide-based compounds

#891
20090253635
2009-10-08

PEPTIDES AND PEPTIDOMIMETICS HAVING ANTI-PROLIFERATIVE ACTIVITY AND/OR THAT AUGMENT NUCLEIC ACID DAMAGING AGENTS OR TREATMENTS

#892
20090252677
2009-10-08

Probes for in vivo targeting of active cysteine proteases

#893
20090246130
2009-10-01

Methods and compositions for F-18 labeling of proteins, peptides and other molecules

#894
20090221008
2009-09-03

NEUTROKINE-ALPHA AND NEUTROKINE-ALPHA SPLICE VARIANT

#895
20090220419
2009-09-03

99m Tc-labeled triphenylphosphonium derivative contrasting agents and molecular probes for early detection and imaging of breast tumors

#896
20090203584
2009-08-13

Peptide-based compounds

#897
20090191225
2009-07-30

Stably tethered structures of defined compositions with multiple functions or binding specificities

#898
20090191124
2009-07-30

PDGF-Rβ binders

#899
20090191123
2009-07-30

Imaging agents

#900
20090180951
2009-07-16

INHIBITORS OF INTEGRIN VLA-4